CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,348 enrolled
Drug / intervention
wearable defibrillatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01446965
NCT01446965N/ACompleted
CompareCT.gov

Vest Prevention of Early Sudden Death Trial: Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator (Formerly VEST/PREDICTS)

University of California, San Francisco·interventional·Posted Oct 5, 2011·Updated Jan 20, 2021

In Brief

A clinical study evaluating wearable defibrillator for Myocardial Infarction and 4 related conditions. Completed, enrolled 2,348 participants across 71 sites in 3 countries.

Detailed Summary

This study explores the hypothesis that wearable defibrillators can impact mortality by reducing sudden death during the first three months after a heart attack in persons with high risk for life-threatening arrhythmias.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyocardial Infarction, Ventricular Dysfunction, Sudden Death, Ventricular Tachycardia, Ventricular Fibrillation
CountriesGermany, Poland, United States
CollaboratorsZoll Medical Corporation

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 5, 2011
Enrollment StartJul 1, 2008
Primary CompletionMay 31, 2019
TodayJul 2, 2026
Enrollment to primary: 10.9 yearsPosted 14.7 years ago

Interventions

wearable defibrillatordevice

LifeVest wearable defibrillator